A six-month randomized control trial testing the impact of sensor tech and connected devices on patient costs and outcomes found no benefit. The Scripps Wired for Health study looked at 160 patients in three condition groups – diabetes, hypertension and arrhythmia – and issued some an iPhone 4 and a connected device allowing them to track their blood pressure, blood glucose or heart rhythms. They study found improved self-management among the patients who monitored their health – but not improved outcomes or lower costs.
Qualcomm is in talks with GSK about a medtech joint venture. Last week, Qualcomm and Novartis announced a deal to incorporate Qualcomm’s connectivity platform into a smart inhaler.
CMS says its Meaningful Use program, a big carrot designed to get providers and health systems on board with EHRs and patient portals, will soon be subsumed by a new and more outcomes-focused program, as ordained by the Medicare Access and CHIP Reauthorization Act, or MACRA, which will measure physicians on four areas, including quality, cost, tech use and practice improvement.
This HuffPo scribe is picking on Accent Health’s waiting room screens, but for me, it flags the need to revisit point of care promotion in an age when everybody has a screen of their own on their person at all times, and we know that patients are looking up health info on their mobile devices at the doctor’s office.
How many liters of saliva 23andMe has collected and other fun facts about the life and times of CEO Anne Wojcicki.
Kentucky’s new Tea Party Republican governor is dismantling Kynect, the state’s standout success of a health insurance marketplace – which may not matter, now that Healthcare.gov is running smoothly.
Meanwhile, on the other side of the political divide, Bernie Sanders is running on promises to enact “Medicare for all,” which is music to progressive ears but maybe shouldn’t be, because Medicare isn’t actually all that and an IV drip from a patient perspective.